Rigorous Integration in a Scalable Development and Manufacturing Enterprise to Support Continued Growth of Biopharmaceuticals

Screen_Shot_2016-09-22_at_3.08.36_PM.pngAs published in Pharma's Almanac Q2 2016.

The pharmaceutical and biopharmaceutical development and manufacturing market continue to experience significant expansion as the development of small molecule drugs and more complex large-molecule biologics rival for attention. Small and midsize pharma/biotech companies
are leading drug discovery and the engagement 
of contract development and manufacturing organizations (CDMOs) helps them to improve capabilities and enable companies to compete 
in this dynamic market.

Topics: Editorials